跳至主要内容
临床试验/NCT02403141
NCT02403141Unknown不适用

Abu Dhabi Sleep Apnea (ADSA) Study

Imperial College London Diabetes Centre1 个研究点 分布在 1 个国家目标入组 1,400 人开始时间: 2015年3月最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,400
试验地点
1
主要终点
Primary objective (Establishing the prevalence of OSA in the study population.)

研究概览

简要总结

Obstructive sleep apnoea (OSA) is a common medical problem which, despite increasing awareness, remains under-diagnosed. There is a close association between OSA and obesity; 60-70% of patients diagnosed with OSA are either obese or overweight [1]. OSA is also very common among patients with type 2 diabetes. Type 2 Diabetes Mellitus (T2DM) has reached epidemic status in the Gulf region. OSA worsens insulin resistance and leads to weight gain through sleep disturbance [2]. Several mechanisms have been proposed for the associations of OSA with diabetes and obesity [3]. At present there is little available information regarding the prevalence of OSA in the UAE, the relationship with T2DM and obesity, and the impact of OSA on health outcomes in the Emirati population. This research will explore these relationships and inform public health decisions regarding diagnostic pathways, service provision and treatment protocols.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Participants aged between 18-64 years old. Both Gender male and female.

排除标准

  • Paediatrics below the age of
  • Any participant who is unable to take part

结局指标

主要结局

Primary objective (Establishing the prevalence of OSA in the study population.)

时间窗: 3 months

Establishing the prevalence of OSA in the study population.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Nader Lessan, MD

Consultant Endocrinologist

Imperial College London Diabetes Centre

研究点 (1)

Loading locations...

相似试验